Gõkhan Metan - Infectious Diseases

Author Information

Gökhan Metan is affiliated with the Department of Infectious Diseases and Clinical Microbiology at the Faculty of Medicine, Hacettepe University, located in Ankara, Turkey. His research appears to be extensively focused on infectious diseases, with a particular interest in the clinical aspects and management of infections.

Research Contributions

Gökhan Metan has made significant contributions to the field of infectious diseases, as evidenced by his varied research outputs. His work includes studies on the performance of SARS-CoV-2 antibody immunoassays, antimicrobial use improvement, organizational models for infection management in surgical pathways, and the effects of genetic polymorphisms on drug serum levels. He has also explored the impact of COVID-19 on other infections, such as invasive pulmonary aspergillosis, and investigated drug-induced nephrotoxicity and disease management following specific treatments.

Aliases

Gökhan Metan is known by several aliases, including Gökhan Metan, G Metan, and Gokhan Metan. These variations reflect different transliterations and abbreviations of his name.

Publication and Citation Metrics

Metric	Value
Paper Count	154
Citation Count	2,536
H-index	25

Publications:

PERFORMANCE EVALUATION OF SIX DIFFERENT SARS-CoV-2 ANTIBODY IMMUNOASSAYS: DISEASE SEVERITY AND SERUM SAMPLING TIME AFFECT THE SENSITIVITY.

DOI: 10.7883/yoken.JJID.2021.636

Year: 2022

Is there still a room for improvement in antimicrobial use in a setting where use of broad-spectrum antibiotics require approval of an infectious diseases physician?

DOI: 10.1017/ice.2022.81

Year: 2022

It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey

DOI: 10.1186/s13017-022-00420-4

Year: 2022

Disseminated Brucella melitensis infection following canakinumab treatment

DOI: 10.1016/j.tmaid.2021.102227

Year: 2022

Colistin Induced Nephrotoxicity: Experience from a University Hospital

DOI: 10.4274/mjima.galenos.2021.2021.53

Year: 2021

Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19

DOI: 10.1155/2021/5509280

Year: 2021

Is COVID-19 a risk factor for invasive pulmonary aspergillosis in critically ill patients?

DOI: 10.5578/tt.20219918

Year: 2021

Surveillance for invasive pulmonary aspergillosis in critically ill patients with COVID-19

DOI: 10.1183/13993003.congress-2021.pa1884

Year: 2021

First Confirmed Cases of 2019 Novel Coronavirus in a University Hospital in Turkey: Housemate Internists

DOI: 10.32552/2020.ACTAMEDICA.476

Year: 2021

Effects of Cytochrome p450 (CYP) 2C19 Genetic Polymorphisms on Voriconazole Serum Levels: A Report of Two Cases

DOI: 10.4274/MJIMA.GALENOS.2021.2021.43

Year: 2021

How Does WHO Respond to Disease Outbreaks?

What Is the Future of Research on Respiratory Droplets?

How Do Antivirals Work?

How Does Hand Hygiene Prevent Infections?

How Can it be Prevented?

What are the Symptoms of Salmonella Infection?

What Factors Influence the Severity of Infection?

What Are Routes of Transmission?

What is the Inflammatory Response?

Can Artemisinin Be Used for Other Infectious Diseases?

Partnered Content Networks

Relevant Topics